A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC
Clinical trial NCT03817658 · UNKNOWN
Trial details
- NCT number
- NCT03817658
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2020-10-01
- Enrollment
- 725
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.